Ó£ÌÒÊÓƵ

03.07.2024 | Published by Genetic Engineering & Biotechnology News

Exclusive interview with Genetic Engineering & Biotechnology News

Featured Image

CEO Mark Kotter shares insights in an exclusive interview with about Ó£ÌÒÊÓƵ's revolutionary CNS Tool Kit, a game-changer for CNS research and drug discovery.

Key Highlights:

Approach: Kotter discusses the shift from traditional directed differentiation methods to deterministic cell programming, significantly speeding up the process of creating human brain cells.

opti-ox: Ó£ÌÒÊÓƵ’s proprietary deterministic programming technology allows for the rapid and consistent production of various brain cell types, including the newly launched ioAstrocytes, complementing the existing ioCells portfolio.

Building Brain Models: these cells can be combined to create detailed and customisable brain models, facilitating the study of cell interactions and disease mechanisms in a human context. ioAstrocytes and other brain cells can be co-cultured to facilitate brain complexity and disease mechanism modeling.

Access the article . 

 

Related pages

About us Coding cells to advance the wellbeing of humanity
Careers See the latest openings
Blog See the latest blogs